A citation-based method for searching scientific literature

Holly J Pederson, Colin O'Rourke, Joanne Lyons, Rebecca J Patrick, Joseph P Crowe, Stephen R Grobmyer. Clin Breast Cancer 2015
Times Cited: 4







List of co-cited articles
34 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography.
Debbie Saslow, Carla Boetes, Wylie Burke, Steven Harms, Martin O Leach, Constance D Lehman, Elizabeth Morris, Etta Pisano, Mitchell Schnall, Stephen Sener,[...]. CA Cancer J Clin 2007
75

Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition.
Mieke Kriege, Cecile T M Brekelmans, Carla Boetes, Peter E Besnard, Harmine M Zonderland, Inge Marie Obdeijn, Radu A Manoliu, Theo Kok, Hans Peterse, Madeleine M A Tilanus-Linthorst,[...]. N Engl J Med 2004
75

Survival analysis of cancer risk reduction strategies for BRCA1/2 mutation carriers.
Allison W Kurian, Bronislava M Sigal, Sylvia K Plevritis. J Clin Oncol 2010
155
50

Comparative effectiveness of screening and prevention strategies among BRCA1/2-affected mutation carriers.
Victor R Grann, Priya R Patel, Judith S Jacobson, Ellen Warner, Daniel F Heitjan, Maxine Ashby-Thompson, Dawn L Hershman, Alfred I Neugut. Breast Cancer Res Treat 2011
69
50

Breast MR imaging screening in women with a history of breast conservation therapy.
Hye Mi Gweon, Nariya Cho, Wonshik Han, Ann Yi, Hyeong-Gon Moon, Dong-Young Noh, Woo Kyung Moon. Radiology 2014
49
50

Screening Breast MRI in Patients Previously Treated for Breast Cancer: Diagnostic Yield for Cancer and Abnormal Interpretation Rate.
Catherine S Giess, Patricia S Poole, Sona A Chikarmane, Dorothy A Sippo, Robyn L Birdwell. Acad Radiol 2015
34
50


Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.
Sepideh Saadatmand, Madeleine M A Tilanus-Linthorst, Emiel J T Rutgers, Nicoline Hoogerbrugge, Jan C Oosterwijk, Rob A E M Tollenaar, Maartje Hooning, Claudette E Loo, Inge-Marie Obdeijn, Eveline A M Heijnsdijk,[...]. J Natl Cancer Inst 2013
45
50

Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk.
Wendie A Berg, Zheng Zhang, Daniel Lehrer, Roberta A Jong, Etta D Pisano, Richard G Barr, Marcela Böhm-Vélez, Mary C Mahoney, W Phil Evans, Linda H Larsen,[...]. JAMA 2012
563
50

Breast MRI screening of women with a personal history of breast cancer.
Sandra Brennan, Laura Liberman, D David Dershaw, Elizabeth Morris. AJR Am J Roentgenol 2010
106
50

Multicenter surveillance of women at high genetic breast cancer risk using mammography, ultrasonography, and contrast-enhanced magnetic resonance imaging (the high breast cancer risk italian 1 study): final results.
Francesco Sardanelli, Franca Podo, Filippo Santoro, Siranoush Manoukian, Silvana Bergonzi, Giovanna Trecate, Daniele Vergnaghi, Massimo Federico, Laura Cortesi, Stefano Corcione,[...]. Invest Radiol 2011
194
50

Sensitivity of MRI versus conventional screening in the diagnosis of BRCA-associated breast cancer in a national prospective series.
Anne I Hagen, Kjell Arne Kvistad, Lovise Maehle, Marit Muri Holmen, Hildegunn Aase, Bodil Styr, Anita Vabø, Jaran Apold, Per Skaane, Pål Møller. Breast 2007
118
50

Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer.
Christiane K Kuhl, Simone Schrading, Claudia C Leutner, Nuschin Morakkabati-Spitz, Eva Wardelmann, Rolf Fimmers, Walther Kuhn, Hans H Schild. J Clin Oncol 2005
644
50

Magnetic resonance imaging of the breast improves detection of invasive cancer, preinvasive cancer, and premalignant lesions during surveillance of women at high risk for breast cancer.
Christopher C Riedl, Lothar Ponhold, Daniel Flöry, Michael Weber, Regina Kroiss, Teresa Wagner, Michael Fuchsjäger, Thomas H Helbich. Clin Cancer Res 2007
67
50

BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study.
Adriana J Rijnsburger, Inge-Marie Obdeijn, Reinoutje Kaas, Madeleine M A Tilanus-Linthorst, Carla Boetes, Claudette E Loo, Martin N J M Wasser, Elisabeth Bergers, Theo Kok, Sara H Muller,[...]. J Clin Oncol 2010
114
50

Cancer screening in the United States, 2018: A review of current American Cancer Society guidelines and current issues in cancer screening.
Robert A Smith, Kimberly S Andrews, Durado Brooks, Stacey A Fedewa, Deana Manassaram-Baptiste, Debbie Saslow, Otis W Brawley, Richard C Wender. CA Cancer J Clin 2018
235
50

Triple-modality screening trial for familial breast cancer underlines the importance of magnetic resonance imaging and questions the role of mammography and ultrasound regardless of patient mutation status, age, and breast density.
Christopher C Riedl, Nikolaus Luft, Clemens Bernhart, Michael Weber, Maria Bernathova, Muy-Kheng M Tea, Margaretha Rudas, Christian F Singer, Thomas H Helbich. J Clin Oncol 2015
134
50

MRI breast screening in high-risk women: cancer detection and survival analysis.
D Gareth Evans, Nisha Kesavan, Yit Lim, Soujanye Gadde, Emma Hurley, Nathalie J Massat, Anthony J Maxwell, Sarah Ingham, Rosalind Eeles, Martin O Leach,[...]. Breast Cancer Res Treat 2014
74
50

Prospective study of breast cancer incidence in women with a BRCA1 or BRCA2 mutation under surveillance with and without magnetic resonance imaging.
Ellen Warner, Kimberley Hill, Petrina Causer, Donald Plewes, Roberta Jong, Martin Yaffe, William D Foulkes, Parviz Ghadirian, Henry Lynch, Fergus Couch,[...]. J Clin Oncol 2011
157
50

Multimodality screening of high-risk women: a prospective cohort study.
Susan P Weinstein, A Russell Localio, Emily F Conant, Mark Rosen, Kathleen M Thomas, Mitchell D Schnall. J Clin Oncol 2009
72
50

Influence of Risk Category and Screening Round on the Performance of an MR Imaging and Mammography Screening Program in Carriers of the BRCA Mutation and Other Women at Increased Risk.
Suzan Vreemann, Albert Gubern-Mérida, Margrethe S Schlooz-Vries, Peter Bult, Carla H van Gils, Nicoline Hoogerbrugge, Nico Karssemeijer, Ritse M Mann. Radiology 2018
27
50

Long-term results of screening with magnetic resonance imaging in women with BRCA mutations.
K Passaperuma, E Warner, P A Causer, K A Hill, S Messner, J W Wong, R A Jong, F C Wright, M J Yaffe, E A Ramsay,[...]. Br J Cancer 2012
110
50

Breast Cancer Screening in Women at Higher-Than-Average Risk: Recommendations From the ACR.
Debra L Monticciolo, Mary S Newell, Linda Moy, Bethany Niell, Barbara Monsees, Edward A Sickles. J Am Coll Radiol 2018
207
50

Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer.
Carol H Lee, D David Dershaw, Daniel Kopans, Phil Evans, Barbara Monsees, Debra Monticciolo, R James Brenner, Lawrence Bassett, Wendie Berg, Stephen Feig,[...]. J Am Coll Radiol 2010
413
50

Imaging Phenotypes in Women at High Risk for Breast Cancer on Mammography, Ultrasound, and Magnetic Resonance Imaging Using the Fifth Edition of the Breast Imaging Reporting and Data System.
Maria Adele Marino, Christopher C Riedl, Maria Bernathova, Clemens Bernhart, Pascal A T Baltzer, Thomas H Helbich, Katja Pinker. Eur J Radiol 2018
10
50

Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS).
M O Leach, C R M Boggis, A K Dixon, D F Easton, R A Eeles, D G R Evans, F J Gilbert, I Griebsch, R J C Hoff, P Kessar,[...]. Lancet 2005
698
50

Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination.
Ellen Warner, Donald B Plewes, Kimberley A Hill, Petrina A Causer, Judit T Zubovits, Roberta A Jong, Margaret R Cutrara, Gerrit DeBoer, Martin J Yaffe, Sandra J Messner,[...]. JAMA 2004
762
50

Screening women at high risk for breast cancer with mammography and magnetic resonance imaging.
Constance D Lehman, Jeffrey D Blume, Paul Weatherall, David Thickman, Nola Hylton, Ellen Warner, Etta Pisano, Stuart J Schnitt, Constantine Gatsonis, Mitchell Schnall,[...]. Cancer 2005
258
50

Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group.
Francesco Sardanelli, Carla Boetes, Bettina Borisch, Thomas Decker, Massimo Federico, Fiona J Gilbert, Thomas Helbich, Sylvia H Heywang-Köbrunner, Werner A Kaiser, Michael J Kerin,[...]. Eur J Cancer 2010
520
50

Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial.
Christiane Kuhl, Stefanie Weigel, Simone Schrading, Birke Arand, Heribert Bieling, Roy König, Bernd Tombach, Claudia Leutner, Andrea Rieber-Brambs, Dennis Nordhoff,[...]. J Clin Oncol 2010
267
50

Breast MRI: EUSOBI recommendations for women's information.
Ritse M Mann, Corinne Balleyguier, Pascal A Baltzer, Ulrich Bick, Catherine Colin, Eleanor Cornford, Andrew Evans, Eva Fallenberg, Gabor Forrai, Michael H Fuchsjäger,[...]. Eur Radiol 2015
175
50

Multicenter comparative multimodality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT study): interim results.
Francesco Sardanelli, Franca Podo, Giuliano D'Agnolo, Arduino Verdecchia, Mariano Santaquilani, Renato Musumeci, Giovanna Trecate, Siranoush Manoukian, Sandro Morassut, Clelia de Giacomi,[...]. Radiology 2007
243
50

Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer.
Ellen Warner, Hans Messersmith, Petrina Causer, Andrea Eisen, Rene Shumak, Donald Plewes. Ann Intern Med 2008
328
50

False-negative MRI breast screening in high-risk women.
A J Maxwell, Y Y Lim, E Hurley, D G Evans, A Howell, S Gadde. Clin Radiol 2017
7
50


High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome.
Virginie Bubien, Françoise Bonnet, Veronique Brouste, Stéphanie Hoppe, Emmanuelle Barouk-Simonet, Albert David, Patrick Edery, Armand Bottani, Valérie Layet, Olivier Caron,[...]. J Med Genet 2013
157
25

Cumulative risk of second primary contralateral breast cancer in BRCA1/BRCA2 mutation carriers with a first breast cancer: A systematic review and meta-analysis.
Esther Molina-Montes, Beatriz Pérez-Nevot, Marina Pollán, Emilio Sánchez-Cantalejo, Jaime Espín, María-José Sánchez. Breast 2014
42
25

Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.
Nasim Mavaddat, Susan Peock, Debra Frost, Steve Ellis, Radka Platte, Elena Fineberg, D Gareth Evans, Louise Izatt, Rosalind A Eeles, Julian Adlard,[...]. J Natl Cancer Inst 2013
498
25

Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group.
S A Narod, J S Brunet, P Ghadirian, M Robson, K Heimdal, S L Neuhausen, D Stoppa-Lyonnet, C Lerman, B Pasini, P de los Rios,[...]. Lancet 2000
385
25

How to spot heritable breast cancer: a primary care physician's guide.
Marissa Smith, Jessica Mester, Charis Eng. Cleve Clin J Med 2014
1
100

Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research.
Rebecca C Fitzgerald, Richard Hardwick, David Huntsman, Fatima Carneiro, Parry Guilford, Vanessa Blair, Daniel C Chung, Jeff Norton, Krishnadath Ragunath, J Han Van Krieken,[...]. J Med Genet 2010
343
25

Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.
Timothy R Rebbeck, Tara Friebel, Theresa Wagner, Henry T Lynch, Judy E Garber, Mary B Daly, Claudine Isaacs, Olufunmilayo I Olopade, Susan L Neuhausen, Laura van 't Veer,[...]. J Clin Oncol 2005
268
25

Peutz-Jeghers syndrome: a systematic review and recommendations for management.
A D Beggs, A R Latchford, H F A Vasen, G Moslein, A Alonso, S Aretz, L Bertario, I Blanco, S Bülow, J Burn,[...]. Gut 2010
341
25

Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer.
L C Hartmann, D J Schaid, J E Woods, T P Crotty, J L Myers, P G Arnold, P M Petty, T A Sellers, J L Johnson, S K McDonnell,[...]. N Engl J Med 1999
919
25

Cancer and Lhermitte-Duclos disease are common in Cowden syndrome patients.
Douglas L Riegert-Johnson, Ferga C Gleeson, Maegan Roberts, Krysta Tholen, Lauren Youngborg, Melvin Bullock, Lisa A Boardman. Hered Cancer Clin Pract 2010
78
25

The genetic attributable risk of breast and ovarian cancer.
E B Claus, J M Schildkraut, W D Thompson, N J Risch. Cancer 1996
507
25

Novel PTEN mutations in patients with Cowden disease: absence of clear genotype-phenotype correlations.
M R Nelen, H Kremer, I B Konings, F Schoute, A J van Essen, R Koch, C G Woods, J P Fryns, B Hamel, L H Hoefsloot,[...]. Eur J Hum Genet 1999
194
25

Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.
Timothy R Rebbeck, Tara Friebel, Henry T Lynch, Susan L Neuhausen, Laura van 't Veer, Judy E Garber, Gareth R Evans, Steven A Narod, Claudine Isaacs, Ellen Matloff,[...]. J Clin Oncol 2004
706
25

Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study.
Susan M Domchek, Tara M Friebel, Susan L Neuhausen, Theresa Wagner, Gareth Evans, Claudine Isaacs, Judy E Garber, Mary B Daly, Rosalind Eeles, Ellen Matloff,[...]. Lancet Oncol 2006
211
25

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.
Timothy R Rebbeck, Henry T Lynch, Susan L Neuhausen, Steven A Narod, Laura Van't Veer, Judy E Garber, Gareth Evans, Claudine Isaacs, Mary B Daly, Ellen Matloff,[...]. N Engl J Med 2002
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.